» Articles » PMID: 10782781

Isolated Demyelinating Syndromes: Comparison of Different MR Imaging Criteria to Predict Conversion to Clinically Definite Multiple Sclerosis

Overview
Specialty Neurology
Date 2000 Apr 27
PMID 10782781
Citations 85
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Purpose: Various authors have developed criteria to classify MR imaging findings that suggest the possibility of multiple sclerosis. The purpose of this study was to evaluate and compare the capacity of three sets of MR imaging criteria for predicting the conversion of isolated demyelinating syndromes to clinically definite multiple sclerosis.

Methods: Seventy patients with clinically isolated neurologic symptoms suggestive of multiple sclerosis were prospectively studied with MR imaging. The MR imaging findings were evaluated by two independent neuroradiologists who were blinded to clinical follow-up data. Based on the clinical outcome at follow-up (presence of a second attack that established clinically definite multiple sclerosis), the sensitivity, specificity, accuracy, positive predictive value, and negative predictive value of the criteria proposed by Paty et al, Fazekas et al, and Barkhof et al were calculated.

Results: Clinically definite multiple sclerosis developed in 22 (31%) patients after a mean follow-up time of 28.3 months. The criteria proposed by Paty et al and those proposed by Fazekas et al showed identical results: sensitivity, 86%; specificity, 54%; accuracy, 64%; positive predictive value, 46%; and negative predictive value, 89%. The criteria proposed by Barkhof et al showed the following: sensitivity, 73%; specificity, 73%; accuracy, 73%; positive predictive value, 55%; and negative predictive value, 85%.

Conclusion: The four dichotomized MR imaging parameters proposed by Barkhof et al are more specific and accurate than the criteria proposed by Paty et al or Fazekas et al for predicting conversion to clinically definite multiple sclerosis.

Citing Articles

Ultrafast Brain MRI at 3 T for MS: Evaluation of a 51-Second Deep Learning-Enhanced T2-EPI-FLAIR Sequence.

Schuhholz M, Ruff C, Burkle E, Feiweier T, Clifford B, Kowarik M Diagnostics (Basel). 2024; 14(17).

PMID: 39272626 PMC: 11393910. DOI: 10.3390/diagnostics14171841.


Review of multiple sclerosis: Epidemiology, etiology, pathophysiology, and treatment.

Haki M, Al-Biati H, Al-Tameemi Z, Ali I, Al-Hussaniy H Medicine (Baltimore). 2024; 103(8):e37297.

PMID: 38394496 PMC: 10883637. DOI: 10.1097/MD.0000000000037297.


Prognostic relevance of MRI in early relapsing multiple sclerosis: ready to guide treatment decision making?.

Hoffmann O, Gold R, Meuth S, Linker R, Skripuletz T, Wiendl H Ther Adv Neurol Disord. 2024; 17:17562864241229325.

PMID: 38332854 PMC: 10851744. DOI: 10.1177/17562864241229325.


How Early Is Early Multiple Sclerosis?.

Stavropoulou De Lorenzo S, Bakirtzis C, Konstantinidou N, Kesidou E, Parissis D, Evangelopoulos M J Clin Med. 2024; 13(1).

PMID: 38202221 PMC: 10780129. DOI: 10.3390/jcm13010214.


The diagnostic value of the central vein sign in radiologically isolated syndrome.

Landes-Chateau C, Levraut M, Okuda D, Themelin A, Cohen M, Kantarci O Ann Clin Transl Neurol. 2024; 11(3):662-672.

PMID: 38186317 PMC: 10963291. DOI: 10.1002/acn3.51986.


References
1.
Poser C, Paty D, Scheinberg L, McDonald W, Davis F, Ebers G . New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol. 1983; 13(3):227-31. DOI: 10.1002/ana.410130302. View

2.
Miller D, Albert P, Barkhof F, Francis G, Frank J, Hodgkinson S . Guidelines for the use of magnetic resonance techniques in monitoring the treatment of multiple sclerosis. US National MS Society Task Force. Ann Neurol. 1996; 39(1):6-16. DOI: 10.1002/ana.410390104. View

3.
Lee K, Hashimoto S, Hooge J, Kastrukoff L, Oger J, Li D . Magnetic resonance imaging of the head in the diagnosis of multiple sclerosis: a prospective 2-year follow-up with comparison of clinical evaluation, evoked potentials, oligoclonal banding, and CT. Neurology. 1991; 41(5):657-60. DOI: 10.1212/wnl.41.5.657. View

4.
Molyneux P, Tubridy N, Parker G, Barker G, MacManus D, Tofts P . The effect of section thickness on MR lesion detection and quantification in multiple sclerosis. AJNR Am J Neuroradiol. 1998; 19(9):1715-20. PMC: 8337483. View

5.
Miller D, Ormerod I, Rudge P, Kendall B, Moseley I, McDonald W . The early risk of multiple sclerosis following isolated acute syndromes of the brainstem and spinal cord. Ann Neurol. 1989; 26(5):635-9. DOI: 10.1002/ana.410260508. View